rxstat › Shortages › Apremilast
Apremilast shortage status
No current shortage
A medication used to treat psoriasis and psoriatic arthritis.
Shortage history
Reports by product
What's happening
There are no active shortage reports for Apremilast.
Apremilast is classified under “IMMUNOSUPPRESSANTS” (ATC L04AA).
Recent changes
- Oct 27, 2026 Shortage resolved
- Oct 5, 2026 Estimated end date pushed back : Oct 9, 2026 → Oct 16, 2026
- Sep 21, 2026 Estimated end date pushed back : Sep 25, 2026 → Oct 9, 2026
- Jul 13, 2026 Estimated end date pushed back : Aug 28, 2026 → Sep 25, 2026
Common questions
What is Apremilast used for?
A medication used to treat psoriasis and psoriatic arthritis.
When will Apremilast be back in stock in Canada?
Apremilast has no active shortage; supply is normal per Health Canada reports.
Why is Apremilast in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (immunosuppressants)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.